BTN1A1

gene
On this page

Also known as BTBTN1

Summary

BTN1A1 (butyrophilin subfamily 1 member A1, HGNC:1135) is a protein-coding gene on chromosome 6p22.2, encoding Butyrophilin subfamily 1 member A1 (Q13410). May function in the secretion of milk-fat droplets.

Butyrophilin is the major protein associated with fat droplets in the milk. It is a member of the immunoglobulin superfamily. It may have a cell surface receptor function. The human butyrophilin gene is localized in the major histocompatibility complex (MHC) class I region of 6p and may have arisen relatively recently in evolution by the shuffling of exons between 2 ancestral gene families

Source: NCBI Gene 696 — RefSeq curated summary.

At a glance

  • GWAS associations: 28
  • Clinical variants (ClinVar): 77 total
  • MANE Select transcript: NM_001732

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:1135
Approved symbolBTN1A1
Namebutyrophilin subfamily 1 member A1
Location6p22.2
Locus typegene with protein product
StatusApproved
AliasesBT, BTN1
Ensembl geneENSG00000124557
Ensembl biotypeprotein_coding
OMIM601610
Entrez696

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000244513, ENST00000684113

RefSeq mRNA: 1 — MANE Select: NM_001732 NM_001732

CCDS: CCDS4614

Canonical transcript exons

ENST00000684113 — 8 exons

ExonStartEnd
ENSE000007035762650159026501937
ENSE000007035802650668326506832
ENSE000008482912650492526505206
ENSE000010388472650806126508087
ENSE000012332652650795026507970
ENSE000039198292650123026501365
ENSE000039202322650030326500358
ENSE000039216332650850126510425

Expression profiles

Bgee: expression breadth broad, 33 present calls, max score 92.22.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0159 / max 7.3217, expressed in 5 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
665320.01595

Top tissues by expression

251 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099192.22gold quality
pancreatic ductal cellCL:000207958.28silver quality
colonic epitheliumUBERON:000039754.80gold quality
bone marrow cellCL:000209254.67gold quality
lymph nodeUBERON:000002954.27gold quality
tibialis anteriorUBERON:000138554.03silver quality
ileal mucosaUBERON:000033151.72silver quality
deltoidUBERON:000147651.59gold quality
vermiform appendixUBERON:000115450.96gold quality
epithelial cell of pancreasCL:000008350.90gold quality
caecumUBERON:000115349.63gold quality
Brodmann (1909) area 46UBERON:000648349.30gold quality
blood vessel layerUBERON:000479749.29gold quality
quadriceps femorisUBERON:000137749.26gold quality
cervix squamous epitheliumUBERON:000692249.20gold quality
hair follicleUBERON:000207349.18gold quality
olfactory bulbUBERON:000226448.92gold quality
choroid plexus epitheliumUBERON:000391148.89gold quality
myocardiumUBERON:000234948.87gold quality
type B pancreatic cellCL:000016948.83gold quality
oviduct epitheliumUBERON:000480448.56gold quality
cardiac muscle of right atriumUBERON:000337948.55gold quality
CA1 field of hippocampusUBERON:000388148.50gold quality
vastus lateralisUBERON:000137948.25gold quality
left ventricle myocardiumUBERON:000656648.24gold quality
orbitofrontal cortexUBERON:000416748.20gold quality
upper arm skinUBERON:000426348.06gold quality
cervix epitheliumUBERON:000480148.04gold quality
tongue squamous epitheliumUBERON:000691947.92gold quality
stromal cell of endometriumCL:000225547.88gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-GEOD-36552yes87.73
E-ENAD-17no10.12
E-ANND-3no3.59

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): SOX9

miRNA regulators (miRDB)

49 targeting BTN1A1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-513A-5P100.0069.772465
HSA-MIR-4673100.0066.641490
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-103A-3P99.9869.141595
HSA-MIR-10799.9869.141595
HSA-MIR-4645-5P99.9865.811284
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-651-3P99.9473.485177
HSA-MIR-497-5P99.9271.832674
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-15A-5P99.9072.802787
HSA-MIR-15B-5P99.9072.782798
HSA-MIR-16-5P99.9072.802780
HSA-MIR-195-5P99.9072.812805
HSA-MIR-6838-5P99.8971.942690
HSA-MIR-424-5P99.8971.902641
HSA-MIR-76599.8468.242442
HSA-MIR-11181-3P99.7566.382205
HSA-MIR-5004-5P99.6866.631294
HSA-MIR-509399.6769.262291
HSA-MIR-875-3P99.6369.472548
HSA-MIR-426199.5970.303415
HSA-MIR-7159-5P99.5372.122472
HSA-MIR-6833-5P99.5068.931161
HSA-MIR-391199.3866.951087
HSA-MIR-6505-3P99.3467.391071
HSA-MIR-472199.2666.05818
HSA-MIR-427999.1966.702437
HSA-MIR-312599.1468.492269

Literature-anchored findings (GeneRIF, showing 3)

  • PRY/SPRY/B30.2 domain of butyrophilin 1A1 (BTN1A1) binds to xanthine oxidoreductase (PMID:19531472)
  • Data illustrated the importance of Akt1 in mammary epithelial cell proliferation, as well as in the regulation of Btn1a1 and subsequent expression of ss-casein. (PMID:21915327)
  • BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1. (PMID:38485289)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusBtn1a1ENSMUSG00000000706
rattus_norvegicusBtn1a1ENSRNOG00000017514

Paralogs (15): BTN3A1 (ENSG00000026950), CD276 (ENSG00000103855), BTN3A3 (ENSG00000111801), BTN2A1 (ENSG00000112763), BTNL8 (ENSG00000113303), HHLA2 (ENSG00000114455), BTN2A2 (ENSG00000124508), VTCN1 (ENSG00000134258), ICOSLG (ENSG00000160223), ERMAP (ENSG00000164010), BTNL9 (ENSG00000165810), BTNL3 (ENSG00000168903), BTN3A2 (ENSG00000186470), BTNL2 (ENSG00000204290), MOG (ENSG00000204655)

Protein

Protein identifiers

Butyrophilin subfamily 1 member A1Q13410 (reviewed: Q13410)

All UniProt accessions (1): Q13410

UniProt curated annotations — full annotation on UniProt →

Function. May function in the secretion of milk-fat droplets. May act as a specific membrane-associated receptor for the association of cytoplasmic droplets with the apical plasma membrane. Inhibits the proliferation of CD4 and CD8 T-cells activated by anti-CD3 antibodies, T-cell metabolism and IL2 and IFNG secretion.

Subunit / interactions. Seems to associate with xanthine dehydrogenase/oxidase.

Subcellular location. Membrane. Secreted.

Post-translational modifications. N-glycosylated.

Similarity. Belongs to the immunoglobulin superfamily. BTN/MOG family.

RefSeq proteins (1): NP_001723* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001870B30.2/SPRYDomain
IPR003599Ig_subDomain
IPR003877SPRY_domDomain
IPR003879Butyrophylin_SPRYDomain
IPR006574PRYDomain
IPR007110Ig-like_domDomain
IPR013106Ig_V-setDomain
IPR013320ConA-like_dom_sfHomologous_superfamily
IPR013783Ig-like_foldHomologous_superfamily
IPR036179Ig-like_dom_sfHomologous_superfamily
IPR037958SPRY/PRY_BTN1/2Domain
IPR043136B30.2/SPRY_sfHomologous_superfamily
IPR050504IgSF_BTN/MOG-likeFamily
IPR053896BTN3A2-like_Ig-CDomain

Pfam: PF00622, PF07686, PF13765, PF22705

UniProt features (19 total): sequence variant 4, domain 3, compositionally biased region 2, glycosylation site 2, disulfide bond 2, topological domain 2, signal peptide 1, chain 1, transmembrane region 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q13410-F184.670.65

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Disulfide bonds (2): 50–124, 164–218

Glycosylation sites (2): 55, 215

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-8851680Butyrophilin (BTN) family interactions
R-HSA-1280218Adaptive Immune System
R-HSA-168256Immune System

MSigDB gene sets: 77 (showing top): GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, GOBP_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOCC_CELL_SURFACE, GOBP_REGULATION_OF_IMMUNE_RESPONSE, GOBP_CYTOKINE_PRODUCTION, MCBRYAN_PUBERTAL_BREAST_3_4WK_UP, MODULE_99, GOBP_T_CELL_RECEPTOR_SIGNALING_PATHWAY, MORF_RAB3A, TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA, GOMF_SIGNALING_RECEPTOR_BINDING, GOCC_SIDE_OF_MEMBRANE, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP

GO Biological Process (2): regulation of cytokine production (GO:0001817), T cell receptor signaling pathway (GO:0050852)

GO Molecular Function (3): signaling receptor binding (GO:0005102), signaling receptor activity (GO:0038023), protein binding (GO:0005515)

GO Cellular Component (5): obsolete extracellular space (GO:0005615), plasma membrane (GO:0005886), external side of plasma membrane (GO:0009897), extracellular region (GO:0005576), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Adaptive Immune System1
Immune System1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
cytokine production1
regulation of gene expression1
regulation of multicellular organismal process1
antigen receptor-mediated signaling pathway1
protein binding1
molecular transducer activity1
binding1
membrane1
cell periphery1
plasma membrane1
cell surface1
side of membrane1

Protein interactions and networks

STRING

814 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
BTN1A1XDHP47989987
BTN1A1PLIN2Q99541972
BTN1A1MFGE8Q08431777
BTN1A1CSN2P05814660
BTN1A1LTFP02788628
BTN1A1MUC1P13931610
BTN1A1PPLO60437563
BTN1A1CD8AP01732563
BTN1A1MUC15Q8N387549
BTN1A1CSN1S1P47710544
BTN1A1CIDEAO60543539
BTN1A1GOT2P00505533
BTN1A1LALBAP00709520
BTN1A1CD4P01730514
BTN1A1PRYO14603476

IntAct

23 interactions, top by confidence:

ABTypeScore
COPS6RHOBTB1psi-mi:“MI:0914”(association)0.730
DCXZBTB5psi-mi:“MI:0914”(association)0.670
BTN1A1MEOX2psi-mi:“MI:0915”(physical association)0.560
BTN1A1MOSPD2psi-mi:“MI:0915”(physical association)0.560
CTLA4B4GALT5psi-mi:“MI:0914”(association)0.530
BTN1A1PPLpsi-mi:“MI:0915”(physical association)0.400
BTN1A1JAMLpsi-mi:“MI:0915”(physical association)0.400
BTN1A1NEGR1psi-mi:“MI:0915”(physical association)0.400
TARM1BTN1A1psi-mi:“MI:0915”(physical association)0.400
METTL3TUBAL3psi-mi:“MI:0914”(association)0.350
METTL14HMGB1P1psi-mi:“MI:0914”(association)0.350
PLK1ERCC6Lpsi-mi:“MI:0914”(association)0.350
NME5INPPL1psi-mi:“MI:0914”(association)0.350
TRIM11LYPLA1psi-mi:“MI:0914”(association)0.350
ATG4ARAB13psi-mi:“MI:0914”(association)0.350
ACTBL2BTN1A1psi-mi:“MI:0914”(association)0.350
SSRP1FABP3psi-mi:“MI:0914”(association)0.350
FHIP2AMED19psi-mi:“MI:2364”(proximity)0.270
BTN1A1MEOX2psi-mi:“MI:0915”(physical association)0.000
MOSPD2BTN1A1psi-mi:“MI:0915”(physical association)0.000

BioGRID (18): BTN1A1 (Affinity Capture-MS), BTN1A1 (Affinity Capture-MS), BTN1A1 (Affinity Capture-MS), BTN1A1 (Affinity Capture-MS), BTN1A1 (Two-hybrid), MOSPD2 (Two-hybrid), BTN1A1 (Affinity Capture-MS), BTN1A1 (Affinity Capture-MS), BTN1A1 (Affinity Capture-MS), BTN1A1 (Affinity Capture-MS), BTN1A1 (Affinity Capture-MS), BTN1A1 (Protein-RNA), BTN1A1 (Affinity Capture-MS), BTN1A1 (Cross-Linking-MS (XL-MS)), BTN1A1 (Cross-Linking-MS (XL-MS))

ESM2 similar proteins: A0A0E4BZH1, A4QPC6, A5D7V5, A7TZE6, A7TZF0, A7TZF3, A7XUX6, A7XV04, A7XV07, A8K4G0, A8MVZ5, O70355, P08508, P18892, P24071, P31994, P55803, P78410, P79391, Q13410, Q16653, Q29ZQ1, Q3KPI0, Q58DF9, Q5R7W8, Q5R960, Q5R996, Q61885, Q62556, Q63345, Q6Q8B3, Q6UXZ3, Q6XJV4, Q6XJV6, Q7KYR7, Q7TST0, Q7YR73, Q8BTP3, Q8K249, Q8TD46

Diamond homologs: A0A0E4BZH1, A4QPC6, A7TZE6, A7TZF0, A7TZF3, A7TZG1, A7TZG3, A7XUX6, A7XUY5, A7XUZ6, A7XV04, A7XV07, A7XV14, A8MVZ5, O00478, O00481, O70355, P18892, P55803, P78410, Q13410, Q16653, Q29ZQ1, Q5R7W8, Q5R960, Q5R996, Q61885, Q62556, Q63345, Q6MG97, Q6UX41, Q6UXE8, Q6UXG8, Q7KYR7, Q7TST0, Q8BJE2, Q8WVV5, Q96KV6, Q96PL5, Q9BGS7

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

77 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance66
Likely benign3
Benign3

Top pathogenic / likely-pathogenic (0)

SpliceAI

587 predictions. Top by Δscore:

VariantEffectΔscore
6:26501933:GGCTG:Gdonor_gain1.0000
6:26501934:GCTGG:Gdonor_gain1.0000
6:26501935:CTGG:Cdonor_loss1.0000
6:26501936:TG:Tdonor_gain1.0000
6:26501937:GG:Gdonor_gain1.0000
6:26501938:G:GGdonor_gain1.0000
6:26501938:GT:Gdonor_loss1.0000
6:26501939:T:Adonor_loss1.0000
6:26501940:G:GTdonor_loss1.0000
6:26508499:A:AGacceptor_gain1.0000
6:26508500:G:GAacceptor_gain1.0000
6:26501584:C:CAacceptor_gain0.9900
6:26501588:A:AGacceptor_gain0.9900
6:26501589:G:GGacceptor_gain0.9900
6:26501941:A:ACdonor_loss0.9900
6:26508499:AGTT:Aacceptor_gain0.9900
6:26508500:GTT:Gacceptor_gain0.9900
6:26508500:GTTG:Gacceptor_gain0.9900
6:26501362:TCAGG:Tdonor_loss0.9800
6:26501363:CAGGT:Cdonor_loss0.9800
6:26501364:AGGTA:Adonor_loss0.9800
6:26501366:G:Adonor_loss0.9800
6:26501367:T:Gdonor_loss0.9800
6:26501585:G:Aacceptor_gain0.9800
6:26501933:GGCT:Gdonor_gain0.9800
6:26501934:GCTG:Gdonor_gain0.9800
6:26504923:A:AGacceptor_gain0.9800
6:26504924:G:GGacceptor_gain0.9800
6:26504924:GCTCT:Gacceptor_gain0.9800
6:26505202:ACCAG:Adonor_loss0.9800

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000092679 (6:26503844 G>C), RS1000264076 (6:26504260 G>C,T), RS1000971796 (6:26509547 A>C), RS1001237209 (6:26505853 T>C), RS1001266921 (6:26506156 A>G), RS1001500649 (6:26502114 C>T), RS1001613720 (6:26498559 T>C), RS1001807520 (6:26505584 C>G), RS1002156712 (6:26506021 A>C), RS1002218235 (6:26500265 C>T), RS1002243035 (6:26507496 T>C), RS1002593695 (6:26499829 G>A), RS1003194323 (6:26507186 A>G), RS1003323249 (6:26499256 A>G), RS1003605133 (6:26499509 T>C,G)

Disease associations

OMIM: gene MIM:601610 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

28 associations (top):

StudyTraitp-value
GCST000301_8Iron status biomarkers6.000000e-08
GCST004521_113Autism spectrum disorder or schizophrenia3.000000e-19
GCST004521_208Autism spectrum disorder or schizophrenia5.000000e-17
GCST004521_215Autism spectrum disorder or schizophrenia5.000000e-13
GCST004521_301Autism spectrum disorder or schizophrenia1.000000e-08
GCST004521_69Autism spectrum disorder or schizophrenia8.000000e-24
GCST005316_551Intelligence (MTAG)2.000000e-11
GCST005316_563Intelligence (MTAG)8.000000e-13
GCST005316_627Intelligence (MTAG)1.000000e-14
GCST007335_33Age at first sexual intercourse2.000000e-07
GCST008152_157Weight6.000000e-06
GCST008158_7Body mass index5.000000e-07
GCST008396_3Educational attainment (years of education)2.000000e-08
GCST008832_6Gastroesophageal reflux disease1.000000e-10
GCST010002_50Refractive error4.000000e-34
GCST010142_16Fish- and plant-related diet2.000000e-10
GCST010142_19Fish- and plant-related diet4.000000e-10
GCST010142_34Fish- and plant-related diet7.000000e-09
GCST010142_35Fish- and plant-related diet8.000000e-09
GCST010142_42Fish- and plant-related diet1.000000e-08
GCST010142_7Fish- and plant-related diet3.000000e-12
GCST010142_74Fish- and plant-related diet9.000000e-09
GCST010142_82Fish- and plant-related diet3.000000e-08
GCST010702_75Subcortical volume (MOSTest)3.000000e-11
GCST010703_272Brain morphology (MOSTest)7.000000e-16
GCST90000514_4Gastroesophageal reflux disease2.000000e-13
GCST90016674_6Liver iron content1.000000e-38
GCST90020028_819Hip circumference adjusted for BMI2.000000e-08

EFO canonical traits (9, from GWAS)

EFO IDTrait name
EFO:0004461iron biomarker measurement
EFO:0004337intelligence
EFO:0009749age at first sexual intercourse measurement
EFO:0004338body weight
EFO:0004340body mass index
EFO:0004784self reported educational attainment
EFO:0008111diet measurement
EFO:0004346neuroimaging measurement
EFO:0008039BMI-adjusted hip circumference

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

10 total (human), top 10 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases methylation, affects cotreatment1
glycidyl methacrylatedecreases expression1
arseniteincreases methylation1
CGP 52608affects binding, increases reaction1
(+)-JQ1 compounddecreases expression1
theaflavin-3,3’-digallateaffects expression1
Resveratrolaffects cotreatment, decreases expression1
Fulvestrantdecreases methylation, affects cotreatment1
Arsenicaffects methylation1
Plant Extractsaffects cotreatment, decreases expression1

Cellosaurus cell lines

2 cell lines: 2 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_E1SGHAP1 BTN1A1 (-) 1Cancer cell lineMale
CVCL_E1SHHAP1 BTN1A1 (-) 2Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): gastroesophageal reflux disease